Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation

Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US

(2013) Anju Parthan et al.   Applied Health Economics and Health Policy

Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom

(2012) Lia Gutiérrez et al.   BONE

The burden of illness of osteoporosis in Canadian men

(2012) Jean-Eric Tarride et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

(2012) John A Eisman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

(2012) C. Roux et al.   OSTEOPOROSIS INTERNATIONAL

Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis

(2012) R. B. Hopkins et al.   OSTEOPOROSIS INTERNATIONAL

The burden of illness of osteoporosis in Canada

(2012) J.-E. Tarride et al.   OSTEOPOROSIS INTERNATIONAL

Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis

(2012) B. McGowan et al.   OSTEOPOROSIS INTERNATIONAL

Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women

(2011) L. Bessette et al.   OSTEOPOROSIS INTERNATIONAL

Incidence of clinically diagnosed vertebral fractures: A population-based study in rochester, minnesota, 1985-1989

(2010) Cyrus Cooper et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

(2010) C. T. Pike et al.   OSTEOPOROSIS INTERNATIONAL

Hip fractures in Italy: 2000–2005 extension study

(2009) P. Piscitelli et al.   OSTEOPOROSIS INTERNATIONAL

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden

(2008) Ström Oskar et al.   Acta Orthopaedica